T0901317 rafenib D3) Smiles: COC1=CC(F)=C(F)C(NC2=CC=C(I)C=C2F)=C1NS(=O)(=O)C1(C[C@H](O)CO)CC1

Smiles: COC1=CC(F)=C(F)C(NC2=CC=C(I)C=C2F)=C1NS(=O)(=O)C1(C[C@H](O)CO)CC1

AKs are serine-threonine kinases that play essential roles in mitotic checkpoint control during mitosis

Recent research shows that Ginsenoside Rb1 affects rat embryo development and has teratogenic effects

and notoginsenoside R1 on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery

(-)-Epinephrine

T0901317 rafenib D3) Smiles: COC1=CC(F)=C(F)C(NC2=CC=C(I)C=C2F)=C1NS(=O)(=O)C1(C[C@H](O)CO)CC1T0901317 is an orally active and highly selective LXR agonist with an EC50 of 20 nM for LXR. T0901317 activates FXR with an EC50 of 5 M. T0901317 is ROR and ROR dual inverse agonist with Ki values of 132 nM and 51 nM, respectively. T0901317 induces apoptosis and inhibits the development of atherosclerosis in low density lipoprotein (LDL) receptor deficient mice. Product information CAS Number: 293754 55 9 Molecular Weight: 481. 33 Formula: